DNA & Synthetic Vaccines


Scientists take many approaches to designing vaccines against a microbe. These choices are typically based on fundamental information about the microbe, such as how it infects cells and how the immune system responds to it, as well as practical considerations, such as regions of the world where the vaccine would be used. A DNA vaccine against a microbe would evoke a strong antibody response to the free-floating antigen secreted by cells, and the vaccine also would stimulate a strong cellular response against the microbial antigens displayed on cell surfaces. The DNA vaccine couldn’t cause the disease because it wouldn’t contain the microbe, just copies of a few of its genes. In addition, DNA vaccines are relatively easy and inexpensive to design and produce. Inactivated vaccines can be composed of either whole viruses or bacteria, or fractions of either. Fractional vaccines are either protein-based or polysaccharide-based.


  • Mechanistic basis for DNA-raised immune responses
  • Plasmid Vector
  • Recombinant protein vaccines
  • Modulation of immune response
  • DNA vaccines delivery

Related Conference of DNA & Synthetic Vaccines

May 30-31, 2024

World congress on Immunology and Virology Diseases

Vienna, Austria
August 01-02, 2024

44th Global Summit and Expo on Vaccines & Immunology

Montreal, Canada
September 09-10, 2024

4th International Conference on Vaccine Research

Madrid, Spain
November 28-29, 2024

6th World Congress on Vaccine and Immunology

Paris, France

DNA & Synthetic Vaccines Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in